BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17996991)

  • 1. Sublingual immunization induces broad-based systemic and mucosal immune responses in mice.
    Cuburu N; Kweon MN; Song JH; Hervouet C; Luci C; Sun JB; Hofman P; Holmgren J; Anjuère F; Czerkinsky C
    Vaccine; 2007 Dec; 25(51):8598-610. PubMed ID: 17996991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating dendritic cells to optimize mucosal immunization protocols.
    Williamson E; Westrich GM; Viney JL
    J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD11c(high )dendritic cells are essential for activation of CD4+ T cells and generation of specific antibodies following mucosal immunization.
    Fahlén-Yrlid L; Gustafsson T; Westlund J; Holmberg A; Strömbeck A; Blomquist M; MacPherson GG; Holmgren J; Yrlid U
    J Immunol; 2009 Oct; 183(8):5032-41. PubMed ID: 19786541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues.
    Imaoka K; Miller CJ; Kubota M; McChesney MB; Lohman B; Yamamoto M; Fujihashi K; Someya K; Honda M; McGhee JR; Kiyono H
    J Immunol; 1998 Dec; 161(11):5952-8. PubMed ID: 9834076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Langerhans cells prime IL-17-producing T cells and dampen genital cytotoxic responses following mucosal immunization.
    Hervouet C; Luci C; Rol N; Rousseau D; Kissenpfennig A; Malissen B; Czerkinsky C; Anjuère F
    J Immunol; 2010 May; 184(9):4842-51. PubMed ID: 20351191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination.
    Song JH; Kim JI; Kwon HJ; Shim DH; Parajuli N; Cuburu N; Czerkinsky C; Kweon MN
    J Immunol; 2009 Jun; 182(11):6851-60. PubMed ID: 19454681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8(+) T cell population in different tissues.
    Qimron U; Paul L; Bar-Haim E; Bloushtain N; Eisenbach L; Staats HF; Porgador A
    Vaccine; 2004 Mar; 22(11-12):1390-4. PubMed ID: 15063561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live varicella vaccine polarizes the mucosal adjuvant action of cholera toxin or its B subunit on specific Th1-type helper T cells with a single nasal coadministration in mice.
    Sasaki K; Kato M; Takahashi T; Ochi S; Ichinose Y; Shiraki K; Asano Y; Iwanaga M; Tsuji T
    J Med Virol; 2003 Jun; 70(2):329-35. PubMed ID: 12696126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice.
    Huang CF; Wu TC; Chu YH; Hwang KS; Wang CC; Peng HJ
    Scand J Immunol; 2008 Nov; 68(5):502-10. PubMed ID: 18822109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice.
    Huang CF; Wang CC; Wu TC; Wu KG; Lee CC; Peng HJ
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):262-71. PubMed ID: 18376242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production.
    Yanagita M; Hiroi T; Kitagaki N; Hamada S; Ito HO; Shimauchi H; Murakami S; Okada H; Kiyono H
    J Immunol; 1999 Mar; 162(6):3559-65. PubMed ID: 10092814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant.
    BenMohamed L; Belkaid Y; Loing E; Brahimi K; Gras-Masse H; Druilhe P
    Eur J Immunol; 2002 Aug; 32(8):2274-81. PubMed ID: 12209640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
    Patel GB; Zhou H; Ponce A; Chen W
    Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal immunization of CD4+ T cell-deficient mice with an inactivated virus induces IgG and IgA responses in serum and mucosal secretions.
    Sha Z; Kang SM; Compans RW
    Virology; 2005 Jan; 331(2):387-95. PubMed ID: 15629781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells.
    Mascarell L; Lombardi V; Louise A; Saint-Lu N; Chabre H; Moussu H; Betbeder D; Balazuc AM; Van Overtvelt L; Moingeon P
    J Allergy Clin Immunol; 2008 Sep; 122(3):603-9.e5. PubMed ID: 18774396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-toxic Stx derivatives from Escherichia coli possess adjuvant activity for mucosal immunity.
    Ohmura-Hoshino M; Yamamoto M; Yuki Y; Takeda Y; Kiyono H
    Vaccine; 2004 Sep; 22(27-28):3751-61. PubMed ID: 15315856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection.
    Cuburu N; Kweon MN; Hervouet C; Cha HR; Pang YY; Holmgren J; Stadler K; Schiller JT; Anjuère F; Czerkinsky C
    J Immunol; 2009 Dec; 183(12):7851-9. PubMed ID: 19933861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal immunization promotes th17 immune responses.
    Zygmunt BM; Rharbaoui F; Groebe L; Guzman CA
    J Immunol; 2009 Dec; 183(11):6933-8. PubMed ID: 19890060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J; Adamsson J; Harandi AM
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.